The past decade has witnessed remarkable progress in the treatment of
children born with a hypoplastic left heart. Compared with a mortality
rate of more than 95% at 1 month of age before surgical intervention
was possible, there is currently a survival rate of almost 60% at 5 ye
ars of age for all newborns with this condition who undergo the Norwoo
d operation, and for newborns given heart transplantations. The curren
t survival rate for all infants suffering from hypoplastic left heart
syndrome and given heart transplantation is almost 80% at the age of 5
years. Uncertainty pertaining to the long-term outlook still exists,
however. Many families and physicians continue to exercise the option
of no treatment. These ethical issues will continue to be argued until
the results of palliative reconstructive surgery or cardiac transplan
tation attain a level of success achieved for other neonatal cardiac o
perations.